15:43 EST Revolution Medicines (RVMD) up 5% after FT says Merck (MRK) in takeover talks
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD:
- Immuneering updated 12-month data for atebimetinib ‘encouraging,’ says Leerink
- Revolution Medicines: Breakthrough-Backed G12D RAS Franchise Strengthens Bullish Risk‑Reward and Supports Buy Rating
- Revolution Medicines announces FDA BTD to zoldonrasib
- Revolution Medicines: Standalone Strength and Strategic M&A Upside Justify Buy Rating
- Revolution Medicines down 15% in after-hours after AbbVie denies takeover talks